5
Pharmaceutical preparations, namely, pharmaceutical preparations for the prevention and/or treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood disorders, cancer/oncology, cardiovascular diseases, cholesterol disorders, central nervous system diseases and disorders, diabetes, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, reproductive system diseases and disorders, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders, anxiety spectrum disorders, atherosclerosis, Alzheimer's; pharmaceutical preparations for use in the prevention and/or treatment of diabetes; pharmaceutical preparations for use in the prevention and/or treatment of rheumatoid arthritis; pharmaceutical preparations for use in the prevention and/or treatment of Crohn's disease, systemic lupus erythematosus, and ankylosing spondylitis disease; pharmaceutical preparations for use in the prevention and/or treatment of psoriasis and psoriatic arthritis; pharmaceutical preparations for use in the prevention and/or treatment of autoimmune disorders; pharmaceutical preparations; antipsychotics; antidepressants